ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Diamond Drugs, INC.

Official 2024 U.S. DOL Form 5500 summary for Diamond Drugs, INC. (Diamond Drugs, INC. 401(k) Plan · EIN 25-1378278 · PN 001): $47.43M net assets, 827 active participants, and $0.91 per $10,000 (0.91 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorDiamond Drugs, INC.
Filing IdentifierDiamond Drugs, INC. 401(k) Plan · EIN 25-1378278 · PN 001
Plan Category & State401(k) Defined Contribution (PA)
Asset-Size Peer Cohort$25M-$100M
Plan Net Assets (2024)$47.43M
Active Participants827
Direct Admin Fee Rate$0.91 per $10,000 (0.91 bps)
Cohort Peer Median$19.23 per $10,000 (19.23 bps)
Primary Recordkeeper / ProviderLincoln Financial Group
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI